脂质代谢
背景(考古学)
肾
机制(生物学)
疾病
肾脏疾病
医学
ABCA1
内科学
内分泌学
生物
运输机
生物化学
哲学
认识论
古生物学
基因
作者
Zhengying Fang,Ruijie Liu,Jingyuan Xie,John Cijiang He
摘要
Abstract Diabetic kidney disease (DKD) is a leading cause of end stage renal disease with unmet clinical demands for treatment. Lipids are essential for cell survival; however, renal cells have limited capability to metabolize overloaded lipids. Dyslipidaemia is common in DKD patients and renal ectopic lipid accumulation is associated with disease progression. Unveiling the molecular mechanism involved in renal lipid regulation is crucial for exploring potential therapeutic targets. In this review, we focused on the mechanism underlying cholesterol, oxysterol and fatty acid metabolism disorder in the context of DKD. Specific regulators of lipid accumulation in different kidney compartment and TREM2 macrophages, a lipid‐related macrophages in DKD, were discussed. The role of sodium‐glucose transporter 2 inhibitors in improving renal lipid accumulation was summarized.
科研通智能强力驱动
Strongly Powered by AbleSci AI